Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Abstract Background Previous studies showed that type 2 short bowel syndrome (SBS) rats were accompanied by severe intestinal bacterial dysbiosis. Limited data are available for intestinal fungal dysbiosis. Moreover, no effective therapeutic drugs are available for these microbiota dysbiosis. The ai...

Full description

Bibliographic Details
Main Authors: Xiuting Hu, Wei Cheng, Shengxian Fan, Yuhua Huang, Xi Chen, Zhiwei Jiang, Jian Wang
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Infectious Diseases
Subjects:
Intestinal bacterial and fungal
Dysbiosis
Short bowel syndrome
Intestinotrophic hormone
Glucagon-like peptide 2
Online Access:https://doi.org/10.1186/s12879-021-06270-w

Internet

https://doi.org/10.1186/s12879-021-06270-w

Similar Items